Bio
Principal at SEP, focusing on therapeutics, specialty pharmaceuticals and contract pharmaceutical services. Led SEP’s investment in the contract research organisation Cmed, which is deploying its proprietary Timaeus technology for the electronic capture and management of clinical trial data. Before joining SEP, was with Dresdner Kleinwort Capital’s Life Science team in London, managing investments in biotechnology and medical device companies in Europe and the US. Registered pharmacist and her previous background is in drug development and clinical research, working for Quintiles, Merck Sharp & Dohme and Sandoz/Novartis. BSc (Hons) and MBA.
Career
|
Scottish Equity Partners LLPEmail: [email protected] |